Antibody Detection + Antibody Testing of Serious Fungal Infections
MiraVista Diagnostics specializes in antibody detection and antibody testing for serious fungal infections. Since 2002, we have been developing and processing diagnostic mycology tests that consistently produce results to the highest standards in clinical accuracy and sensitivity.
Antibody Detection Test Results You Can Trust
MiraVista Diagnostics currently offers immunodiffusion and EIA antibody detection tests for aspergillus, histoplasma, blastomyces and coccidioides. Download a test menu or contact us to learn more about our antibody detection tests.
MiraVista Diagnostics Supports Fungal Disease Awareness Week
August 14–18, 2017, is the first Fungal Disease Awareness Week. CDC and partners have organized this week to highlight the importance of recognizing serious fungal diseases early enough in the course of a patient’s illness to provide life-saving treatment. MiraVista…
READ MORE →
MiraVista is Participating in the 2017 Coccidioidomycosis Study Group Symposium
MiraVista Diagnostics is participating in the 2017 Coccidioidomycosis Study Group Symposium on August 11-13 at the Stanford University Medical School. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of diagnostic tests for serious fungal infections….
READ MORE →
NEW: MVista® Histoplasma Antibody IgG IgM EIA
Improve Diagnosis of Acute Pulmonary Histoplasmosis by Combining Antigen & Antibody Testing Review the technical specifications for the NEW MVista® Histoplasma Antibody IgG IgM EIA>> CLINICAL BACKGROUND Acute pulmonary histoplasmosis (APH) can be severe, especially following heavy exposure and is…
READ MORE →
BULLETIN: CSTE Revised Its Histoplasmosis Position Statement at the 2016 Annual Conference
The Council of State and Territorial Epidemiologists (CSTE) approved the Infectious Disease Committee’s revisions to the histoplasmosis position statement, “Standardized Surveillance Case Definition for Histoplasmosis” at the organization’s annual conference in Anchorage, Alaska on June 19-23, 2016. Review the revised…
READ MORE →
FEATURE: Diagnosing Histoplasmosis by Antigen Detection
FEATURED CASE REPORT FROM THE DESK OF: Lawrence Joseph Wheat, MD Medical Director, Founder & President of MiraVista Diagnostics Here is an important patient case report I’d like to share with colleagues about diagnosing histoplasmosis by antigen detection. I welcome…
READ MORE →
NEW: MVista® Coccidioides Antibody IgG IgM EIA
Improve Coccidioidomycosis Diagnosis with a New, More Sensitive, Anti-Coccidioides Antibody Enzyme Immunoassay CLINICAL BACKGROUND Coccidioidomycosis is endemic to the southwestern United States, northern Mexico and regions of Central and South America. Coccidioidomycosis often presents as community acquired pneumonia (CAP) and…
READ MORE →
